The Importance of Early and Accurate Diagnosis and Treatment of ILD and IPF
June 24, 2020
June 24, 2021
Scroll to the Bottom of this Information to Begin this Course
This collaborative program was developed and presented by National Jewish Health with the Mount Sinai – National Jewish Health Respiratory Institute and the Jane and Leonard Korman Respiratory Institute - Jefferson Health and National Jewish Health. Together, these three organizations collaborate on research, clinical trials and other programs extending the impact they bring to patients and furthering the understanding of respiratory illness. The Respiratory Institute model of collaboration currently brings these three entities together, collectively referred to as “The Respiratory Institutes”.
The Respiratory Institutes provide specialized programs committed to multidisciplinary consultation, advanced diagnostics, and coordinated, collaborative care for the full range of lung conditions. With expert faculty working in sync, the Institutes are well-positioned to provide education to health care providers on best practices in respiratory medicine and improving overall care coordination.
This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™
All other health care professionals completing this course will be issued a statement of participation.
This activity contains four 15-minute chapters each worth .25 credit. Learners can consume all or part of the segments.
The American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credits™ issued by organizations accredited by the ACCME (Accreditation Council for Continuing Medical Education) for Nurse Practitioners and Advanced Practice Registered Nurses.
The National Commission on Certification of Physician Assistants (NCCPA) States that AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification.
This activity is designed to meet the educational needs of Pulmonologists, Radiologists, Pathologists along with Primary Care Physicians, Nurse Practitioners, and Physician Assistants who treat patients with ILD.
The goal of this online program is to improve health care providers’ knowledge, competence and performance to close gaps related to early guideline-concordant diagnosis, management, and treatment of patients with Interstitial Lung Diseases (ILD) and Idiopathic Pulmonary Fibrosis (IPF). Topics included in the program are the natural history of IPF/ILD, early and accurate guideline-based diagnosis, differentiating IPF from other Interstitial Lung Diseases (ILD), and early initiation of treatment to improve patient outcomes.
Upon completion of this activity, participants should be better able to:
- Integrate new information about the natural history of IPF and other ILDs into clinical decision-making and discussions with patients about their prognosis.
- Employ best practices for the early and accurate diagnosis of IPF and other ILDs.
- Develop pharmacologic and non-pharmacologic treatment plans for patients with IPF that help to preserve lung function and manage symptoms.
Amy Olson, MD, MSPH (Program Chair)
Department of Medicine
Division of Pulmonary, Critical Care and Sleep Medicine
National Jewish Health
Contributing Clinical Faculty
Maria Padilla, MD
Director, Advanced Lung Disease/Interstitial Lung Disease Program
Professor of Medicine
Pulmonary, Critical Care and Sleep Medicine
Mount Sinai-National Jewish Health Respiratory Institute
New York City, NY
Jesse Roman, MD
Professor of Medicine
CEO, Jane & Leonard Korman Respiratory Institute – Jefferson Health and National Jewish Health
Ludwig Kind Professor of Medicine and Pharmacology & Experimental Therapeutics
Enterprise Division Chief, Pulmonary, Allergy and Critical Care Medicine
National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
National Jewish Health designates this enduring activity for a maximum of 1.0 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
Disclosures of Conflicts of Interest
In accordance with ACCME requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below.
Amy Olson, MD, MSPH (Program Chair) discloses that she is on an advisory board, a speaker and conducts research for Boehringer Ingelheim. She is also a speaker for Genentech, PeerView, Pilot/France Foundation and Vindico as well as on the Board of Directors for MedGraphics.
Contributing Clinical Faculty
Maria Padilla, MD discloses that she is a consultant for Boehringer Ingelheim, a speaker for Eastern Pulmonary Conference, Genentech, Takeda and Vindico as well as a shareholder with Amgen.
Jesse Roman, MD discloses that he is on an advisory board for IPF/ILD-PRO as we as an investigator for Bellerophon Therapeutics, Galapagos, Galecto Biotech, Genentech, IPF/ILD-PRO and Fibrogen.
Faculty, Planners and Reviewers: Michael Mohning, MD, Stephanie Corder, ND, RN, Andrea Harshman, MHA, CHCP, CMP-HC, L. Scott Stevenson, and Mandy Comeau have no relevant financial relationships to report.
Disclosure of Unlabeled Use
National Jewish Health requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Method of Participation
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Submit the evaluation form.
Course Viewing Requirements
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.